Compare MLAB & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLAB | OFIX |
|---|---|---|
| Founded | 1982 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 461.9M | 473.3M |
| IPO Year | 1995 | 1998 |
| Metric | MLAB | OFIX |
|---|---|---|
| Price | $105.89 | $12.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $94.00 | $17.25 |
| AVG Volume (30 Days) | 85.7K | ★ 221.4K |
| Earning Date | 05-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.67% | N/A |
| EPS Growth | ★ 99.24 | 29.39 |
| EPS | ★ 1.95 | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | $6.07 | $6.13 |
| Revenue Next Year | $5.41 | $6.22 |
| P/E Ratio | $53.24 | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $59.63 | $10.25 |
| 52 Week High | $128.55 | $16.99 |
| Indicator | MLAB | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 65.71 | 51.28 |
| Support Level | $69.73 | $10.94 |
| Resistance Level | $106.28 | $12.99 |
| Average True Range (ATR) | 4.43 | 0.56 |
| MACD | 0.17 | 0.01 |
| Stochastic Oscillator | 92.48 | 58.39 |
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.